Community Research and Development Information Service - CORDIS

FP7

MICAG — Result In Brief

Project ID: 249313
Funded under: FP7-PEOPLE
Country: Germany

Microbiota determine gut vessel formation

The mammalian gut has co-evolved with trillions of colonising bacteria. A European study worked to understand the impact of these bacteria on gut vascularisation and unravel the implicated mechanisms.
Microbiota determine gut vessel formation
Studies on mice raised in germ-free conditions suggest an involvement of gut microbes in gut vascularisation. When these animals are placed back in a normal environment, extensive capillary formation is observed. This indicates that microbial infection switches on the expression of a pro-angiogenic gene repertoire in the intestinal mucosa.

Based on this, the EU-funded 'Microbial-induced angiogenesis in the gut' (MICAG) project wished to elucidate how gut microbes affect intestinal morphology and trigger vessel formation. Conventional mice (CONV-R) and germ-free–born mice raised under conventional conditions (CONV-D) were used to investigate the expression of various angiogenic factors in the intestinal mucosa.

Upon microbial colonisation, an altered expression of the protease-activated receptor 1 (PAR-1) coagulation pathway was observed in the enterocytes. These changes were linked to alterations in the signalling pathway of Angiopoietin-1/Tie-2. Analysis of the small intestine of mice deficient in PAR-1 and PAR-2 receptors confirmed changes in new blood vessel formation. Results clearly indicate that the extrinsic coagulation pathway contributes to vascular remodelling in the small intestinal mucosa. No changes in the VEGF pathway could be observed, suggesting that it is of less importance in mucosal vascular remodelling.

Since increased angiogenesis is described as a hallmark of Crohn's disease, these mechanisms have important clinical ramifications. A detailed understanding of how microbes affect intestinal morphogenesis could help delineate disease pathogenesis and identify avenues of therapeutic exploitation.

Related information

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top